Hitoshi Ishii Selected Research

Sodium-Glucose Transporter 2 Inhibitors

1/2018

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hitoshi Ishii Research Topics

Disease

34	Type 2 Diabetes Mellitus (MODY) 10/2023 - 09/2008
10	Hypoglycemia (Reactive Hypoglycemia) 12/2023 - 08/2008
6	Body Weight (Weight, Body) 02/2021 - 01/2017
3	Diabetes Mellitus 01/2023 - 11/2013
3	Diabetic Nephropathies (Diabetic Nephropathy) 08/2016 - 01/2014
2	Hyperglycemia 12/2023 - 01/2014
2	Diabetes Complications 01/2020 - 05/2018
2	Weight Gain 04/2019 - 01/2012
2	Albuminuria 04/2018 - 08/2016
2	Insulin Resistance 02/2016 - 03/2014
2	Atherosclerosis 01/2016 - 03/2014
1	Lactic Acidosis 01/2023
1	Human Influenza (Influenza) 10/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021
1	Body Weight Changes 03/2020
1	Acute Coronary Syndrome 03/2020
1	Nausea 01/2020
1	Nasopharyngitis 01/2020
1	Constipation 01/2020
1	Infections 01/2018
1	Polyuria 01/2018
1	Medically Unexplained Symptoms 01/2018
1	Overweight 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2017
1	Hypopituitarism (Sheehan's Syndrome) 10/2017
1	Chronic Renal Insufficiency 12/2016
1	Lipodystrophy 02/2016
1	Abdominal Obesity 02/2016
1	Non-alcoholic Fatty Liver Disease 02/2016
1	Alcoholic Fatty Liver 02/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Inflammation (Inflammations) 09/2014
1	Crohn Disease (Crohn's Disease) 01/2014

Drug/Important Bio-Agent (IBA)

19	Insulin (Novolin)FDA Link 02/2021 - 08/2008
5	Blood Glucose (Blood Sugar)IBA 03/2020 - 08/2008
4	dulaglutideIBA 12/2023 - 05/2018
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2021 - 01/2014
4	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 03/2011
3	Hypoglycemic Agents (Hypoglycemics)IBA 03/2020 - 01/2018
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 02/2016
3	Uric Acid (Urate)IBA 10/2017 - 08/2016
3	AlbuminsIBA 01/2017 - 01/2016
3	CreatinineIBA 01/2017 - 01/2016
3	C-Reactive ProteinIBA 11/2014 - 03/2014
2	BiguanidesIBA 01/2023 - 01/2018
2	dapagliflozinIBA 12/2020 - 01/2018
2	trelagliptinIBA 08/2019 - 12/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2018 - 01/2017
2	Liraglutide FDA Link 01/2017 - 01/2014
1	tirzepatideIBA 12/2023
1	2- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA 10/2023
1	A-factor (Streptomyces)IBA 03/2019
1	voglibose (Basen)IBA 06/2018
1	LinagliptinIBA 06/2018
1	Insulin Glargine (Lantus)FDA Link 05/2018
1	Proton Pump InhibitorsIBA 04/2018
1	GlucosidasesIBA 01/2018
1	Sodium-Glucose Transport ProteinsIBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Growth Hormone (Somatotropin)IBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Sitagliptin Phosphate (Januvia)FDA Link 06/2017
1	ThiazolidinedionesIBA 02/2016
1	Pioglitazone (Actos)FDA Link 02/2016
1	Collagen Type IV (Type IV Collagen)IBA 02/2016
1	alogliptinIBA 02/2016
1	Antifibrotic AgentsIBA 02/2016
1	Ferritins (Ferritin)IBA 02/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	CytokinesIBA 03/2014
1	AdipokinesIBA 03/2014
1	BilirubinIBA 01/2014
1	C-PeptideIBA 01/2014
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 03/2011

Therapy/Procedure

13	Therapeutics 02/2021 - 03/2011
13	Glycemic Control 02/2021 - 03/2011
1	Drug Prescriptions 10/2021
1	Diet Therapy (Therapy, Diet) 12/2020
1	Exercise Therapy (Therapy, Exercise) 06/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 02/2016
1	Injections 11/2013